Showing results (771-780 of 1,211) with videos related to

Sort By:
Pageof 122
European Journal of Heart Failure|November 24, 2023
Albuminuria in transthyretin cardiac amyloidosis: Prevalence, progression and prognostic importanceAdam Ioannou, Muhammad U Rauf, Rishi K Patel, et al.
European Heart Journal|August 26, 2023
Upgrade of right ventricular pacing to cardiac resynchronization therapy in heart failure: a randomized trialBéla Merkely, Robert Hatala, Jerzy K Wranicz, et al.
Circulation|April 16, 2016
Global Electric Heterogeneity Risk Score for Prediction of Sudden Cardiac Death in the General Population: The Atherosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) StudiesJonathan W Waks, Colleen M Sitlani, Elsayed Z Soliman, et al.
JACC. Heart Failure|October 31, 2025
Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of CRD-740, a PDE9 Inhibitor, in Chronic Heart FailureJames E Udelson, Jan Bělohlávek, Andrej Dukát, et al.
European Journal of Heart Failure|March 2, 2026
Dipstick proteinuria and outcomes in patients with heart failure and reduced ejection fraction: insights from GALACTIC-HFRyohei Ono, Misato Chimura, Kieran F Docherty, et al.
European Journal of Heart Failure|April 10, 2026
Kidney Failure Risk Equation and Risk of Kidney and Cardiovascular Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: Insights from PARADIGM-HFIris E Beldhuis, Brian L Claggett, Brendon L Neuen, et al.
European Journal of Heart Failure|May 14, 2024
Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS-HF trialMuthiah Vaduganathan, Brian L Claggett, Carolyn S P Lam, et al.
Journal of the American College of Cardiology|January 2, 2025
Systolic Blood Pressure and Pulse Pressure in Heart Failure: Pooled Participant-Level Analysis of 4 TrialsHenri Lu, Toru Kondo, Brian L Claggett, et al.
JACC. Heart Failure|November 21, 2024
Angiotensin Receptor Neprilysin Inhibition and Cardiovascular Outcomes Across the Kidney Function Spectrum: The PARAGON-HF TrialFinnian R Mc Causland, Muthiah Vaduganathan, Brian Claggett, et al.
European Journal of Heart Failure|May 29, 2021
Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trialScott D Solomon, Rudolf A de Boer, David DeMets, et al.
Pageof 122